InvestorsHub Logo
Followers 145
Posts 27566
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Saturday, 01/21/2017 7:25:43 AM

Saturday, January 21, 2017 7:25:43 AM

Post# of 44784
Maxim Group Reiterates “$3.00” Price Target for Pluristem

January 20th, 2017 - By Renee Jackson - 0 comments

Pluristem Therapeutics Inc. logoMaxim Group set a $3.00 price target on Pluristem Therapeutics Inc. (NASDAQ:PSTI) in a report released on Tuesday. The brokerage currently has a buy rating on the stock.